- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03586271
Comparison of the Visual Performance After Implantation of Multifocal Lens
July 2, 2018 updated by: Aier School of Ophthalmology, Central South University
Comparison of the Visual Performance After Implantation of a Trifocal Intraocular Lens(AT Lisa Tri 839MP) and Two Bifocal Intraocular Lenses(ReSTOR +2.5/+ 3.0D and Diff-aay)
This is a prospective, consecutive, nonrandomized,comparative study.
Comparison of the Visual Performance After Implantation of a Trifocal Intraocular Lens and Two Bifocal Intraocular Lenses
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Multifocal intraocular lenses were introduced in the 1980s and have the benefit of promoting near and far vision simultaneous.
However, these multifocal lenses have the disadvantages, including lower contrast sensitivity(CS) and visual discomfort, such as halos, glares and starburst, et al.
Therefore, careful patient selection is crucial to achieve good postoperative results.
The purpose of this study was to compare the visual outcomes and subjective visual quality between bifocal intraocular Lens(ReSTOR +2.5/+ 3.0D and Diff-aay) and trifocal intraocular Lens(AT Lisa tri 839MP).
This prospective, nonrandomized, consecutive, comparative study included the assessment of 60 patients implanted with multifocal intraocular lens.
visual acuity was tested in all cases.
Ophthalmological evaluation included the measurement of uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), uncorrected near visual acuity (UNVA), and uncorrected intermediate visual acuity (UIVA), the analysis of contrast sensitivity (CS), visual defocus curve, spectacle independence, patient satisfaction, residual sphere, spherical equivalent (SE), cylinder and complications.
Study Type
Observational
Enrollment (Anticipated)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Shanghai, China, 200000
- Recruiting
- Wensheng Li
-
Contact:
- Hua Fan
- Phone Number: +8618650424985 +8618988761617
- Email: fanhua1116@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
cataract patients
Description
Inclusion Criteria:
- cataract
Exclusion Criteria:
- existence of any corneal disease;
- previous eye surgery;
- illiteracy;
- previous refractive surgery;
- expected postoperative corneal astigmatism more than 1.00D;
- higer-order aberration more than 0.3;
- spherical aberration more than 0.3μm;
- intraoperative or postoperative complications.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
trifocal lens
trifocal lens implantation(AT Lisa tri 839MP)
|
phacoemusification +bifocal lens(Diff-aay) implantation
phacoemusification +bifocal lens (ReSTOR +3.0D) implantation
phacoemusification +bifocal lens (ReSTOR +2.5D) implantation
|
|
bifocal lens 1
bifocal lens implantation(Diff-aay)
|
phacoemusification +bifocal lens (ReSTOR +3.0D) implantation
phacoemusification +bifocal lens (ReSTOR +2.5D) implantation
phacoemusification + trifocal lens(AT Lisa tri 839MP) implantation
|
|
bifocal lens 2
bifocal lens implantation(ReSTOR +3.0D)
|
phacoemusification +bifocal lens(Diff-aay) implantation
phacoemusification +bifocal lens (ReSTOR +2.5D) implantation
phacoemusification + trifocal lens(AT Lisa tri 839MP) implantation
|
|
bifocal lens 3
bifocal lens implantation(ReSTOR +2.5D)
|
phacoemusification +bifocal lens(Diff-aay) implantation
phacoemusification +bifocal lens (ReSTOR +3.0D) implantation
phacoemusification + trifocal lens(AT Lisa tri 839MP) implantation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Uncorrected distance visual acuity
Time Frame: 3 months after surgery
|
Uncorrected distance visual acuity (4m) were measured using the reading table model of the Early Treatment Diabetic Retinopathy Study charts (ETDRS; Vector Vision, Ltd, Greenville, OH, USA).
|
3 months after surgery
|
|
Uncorrected near visual acuity
Time Frame: 3 months after surgery
|
Uncorrected near visual acuity (40cm) were measured using the reading table model of the Early Treatment Diabetic Retinopathy Study charts (ETDRS; Vector Vision, Ltd, Greenville, OH, USA).
|
3 months after surgery
|
|
Uncorrected intermediate visual acuity
Time Frame: 3 months after surgery
|
Uncorrected intermediate visual acuity (60cm) were measured using the reading table model of the Early Treatment Diabetic Retinopathy Study charts (ETDRS; Vector Vision, Ltd, Greenville, OH, USA).
|
3 months after surgery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of vision
Time Frame: 3 months after surgery
|
Quality of vision was measured using the National Eye Institute Visual Function Questionnaire (NEI VFQ)-25.
The NEI-VFQ was developed at the RAND under the sponsorship of the NEI; it provides a self-reported measure of visual function.
|
3 months after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Wensheng Li, Shanghai Aier Eye Hosptial
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- de Medeiros AL, de Araujo Rolim AG, Motta AFP, Ventura BV, Vilar C, Chaves MAPD, Carricondo PC, Hida WT. Comparison of visual outcomes after bilateral implantation of a diffractive trifocal intraocular lens and blended implantation of an extended depth of focus intraocular lens with a diffractive bifocal intraocular lens. Clin Ophthalmol. 2017 Oct 26;11:1911-1916. doi: 10.2147/OPTH.S145945. eCollection 2017.
- Gundersen KG, Potvin R. Comparison of visual outcomes after implantation of diffractive trifocal toric intraocular lens and a diffractive apodized bifocal toric intraocular lens. Clin Ophthalmol. 2016 Mar 17;10:455-61. doi: 10.2147/OPTH.S103375. eCollection 2016.
- Xu Z, Cao D, Chen X, Wu S, Wang X, Wu Q. Comparison of clinical performance between trifocal and bifocal intraocular lenses: A meta-analysis. PLoS One. 2017 Oct 26;12(10):e0186522. doi: 10.1371/journal.pone.0186522. eCollection 2017.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 2, 2018
Primary Completion (Anticipated)
January 1, 2019
Study Completion (Anticipated)
February 1, 2019
Study Registration Dates
First Submitted
June 15, 2018
First Submitted That Met QC Criteria
July 2, 2018
First Posted (Actual)
July 13, 2018
Study Record Updates
Last Update Posted (Actual)
July 13, 2018
Last Update Submitted That Met QC Criteria
July 2, 2018
Last Verified
May 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- SHIRB2018016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
all IPD that underlie results
IPD Sharing Time Frame
After this study is finished the data will become available for 1year.
IPD Sharing Access Criteria
The analytical data will be accessed in published articles.
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intraocular Lens
-
University Hospital AugsburgRecruitingIntraocular Lens Rotation | Lens Opacities | Intraocular Lens Associated Postoperative Inflammation | Intraocular Lens ComplicationGermany
-
St John of God Hospital, ViennaRecruitingIntraocular LensAustria
-
Teleon Surgical B.V.Charite University, Berlin, GermanyCompleted
-
Medical University of ViennaCompleted
-
Medicontur Medical Engineering LtdCompletedCataract | Pseudophakia | Intraocular Lens Complication | Intraocular Lens OpacificationHungary
-
Medicontur Medical Engineering LtdCompletedCataract | Pseudophakia | Intraocular Lens Complication | Intraocular Lens OpacificationHungary
-
Faculty Hospital Kralovske VinohradyRecruitingIntraocular LensCzechia, Slovakia
-
Faculty Hospital Kralovske VinohradySomich, s.r.o.; Očni centrum Praha a.s.Recruiting
-
Taipei Nobel Eye ClinicCompleted
-
Sensor CliniqRecruitingCataract | Intraocular LensPoland
Clinical Trials on bifocal lens 1
-
Carl Zeiss Meditec AGCompleted
-
University of RochesterCompleted
-
Clerio Vision, Inc.Completed
-
The Hong Kong Polytechnic UniversityCompleted
-
Ohio State UniversityNational Eye Institute (NEI)Completed
-
University Eye Hospital SvjetlostCompletedCataract | Visual Acuity | Presbyopia CorrectionCroatia
-
Essilor InternationalQueensland University of TechnologyCompleted
-
National Eye Institute (NEI)UnknownStrabismus | Myopia | Esophoria
-
CooperVision, Inc.Completed
-
CooperVision International Limited (CVIL)CompletedPresbyopiaUnited Kingdom